ASSOCIATION DE L'INHIBITEUR DU TAFIa ET DE L'ACTIVATEUR DU PLASMINOGÈNE

• 收藏
• 分享

专利权人:

Daiichi Sankyo Company; Limited

发明人:

申请号：

EP16811713.3

公开号：

EP3311812A1

申请日:

2016.06.16

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention provides a pharmaceutical composition for treatment or prevention of thrombosis or embolism or a sequela thereof, comprising a particular TAFIa inhibitor and a plasminogen activator, the TAFIa inhibitor being administered in combination with the plasminogen activator, and a method for treating or preventing thrombosis or embolism or a sequela thereof, comprising administering a particular TAFIa inhibitor in combination with a plasminogen activator to a warm-blooded animal.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/